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Randomized trials have demonstrated a survival benefit for endovascular treatment of rup-
tured cerebral aneurysms. We investigated the association of surgical clipping and endo-
vascular coiling with outcomes in subarachnoid hemorrhage (SAH) patients in a real-world
regional cohort.
Methods
We performed a cohort study involving patients with ruptured cerebral aneurysms, who
underwent surgical clipping, or endovascular coiling from 2009–2013 and were registered
in the Statewide Planning and Research Cooperative System (SPARCS) database. An
instrumental variable analysis was used to investigate the association of treatment tech-
nique with outcomes.
Results
Of the 4,098 patients undergoing treatment, 2,585 (63.1%) underwent coiling, and 1,513
(36.9%) underwent clipping. Using an instrumental variable analysis, we did not identify a
difference in inpatient mortality [marginal effect (ME), -0.56; 95% CI, -1.03 to 0.02], length of
stay (LOS) (ME, 1.72; 95% CI, -3.39 to 6.84), or the rate of 30-day readmissions (ME, -0.30;
95% CI, -0.82 to 0.22) between the two treatment techniques for patients with SAH. Clipping
was associated with a higher rate of discharge to rehabilitation (ME, 0.63; 95% CI, 0.24 to
1.01). In sensitivity analysis, mixed effect regression, and propensity score adjusted regres-
sion models demonstrated identical results.
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Conclusions
Using a comprehensive all-payer cohort of patients in New York State presenting with aneu-
rysmal SAH we did not identify an association of treatment method with mortality, LOS or
30-day readmission. Clipping was associated with a higher rate of discharge to
rehabilitation.
Introduction
Cerebral aneurysm rupture and subarachnoid hemorrhage (SAH) have catastrophic conse-
quences, with major morbidity and mortality.[1–3] Surgical clipping or endovascular coiling
can be used to secure the aneurysm and prevent further bleeding.[1] In 2002, the International
Study for Aneurysm Treatment (ISAT)[4] demonstrated that the minimally invasive option of
coiling is associated with improved mortality one year postoperatively. These results, although
initially highly controversial,[5] were subsequently confirmed in a single-center randomized
trial in the United States.[6] Following the publication of these results, endovascular treatment
of ruptured cerebral aneurysms has become the predominant option in SAH.[7] However, the
relative effectiveness of clipping and coiling has not been studied extensively in the community.
This is particularly important, given the concerns that have been raised about the lack of uni-
fied certification criteria for endovascular practitioners.[2, 3]
However, observational studies attempting to answer this question are subject to selection
bias. Patients included in retrospective analyses were selected for either procedure in advance.
This selection typically reflects the different preferences and backgrounds of the treating physi-
cians, as well as specific patient characteristics, and anatomic information such as aneurysm
size, shape and location. Administrative databases lack such granularity, thus limiting the abil-
ity to control for such confounders. This introduces significant unmeasured confounding.
There has been no prior study attempting to account for these limitations through different
analytic approaches in an adult cohort of all ages.
We used the New York Statewide Planning and Research Cooperative System (SPARCS)[8]
to study the association of treatment technique with mortality, discharge to rehabilitation,
30-day readmission, and length of stay for patients undergoing surgical clipping or endovascu-
lar coiling for ruptured cerebral aneurysms. An instrumental variable analysis was used to con-
trol for unmeasured confounding and simulate the effect of randomization.
Methods
New York Statewide Planning and Research Cooperative System
(SPARCS)
The Dartmouth Committee for Protection of Human Subjects has approved this analysis as
this is de-identified database. All patients with ruptured cerebral aneurysms who were regis-
tered in the SPARCS (New York State Department of Health, Albany, NY)[8] database between
2009 and 2013 were included in the analysis. For these years, SPARCS contains patient-level
details for every hospital discharge, ambulatory surgery, and emergency department admission
in New York State as coded from admission and billing records. This is an all payer database.
SPARCS is different from other administrative databases by providing information on the spe-
cific physician, and hospital where the patient received treatment. Additionally, the ZIP code
of the patient’s residence is available to the researchers. In our analysis, we used the limited
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version (not the public use file) of the dataset. More information about SPARCS is available at
https://www.health.ny.gov/statistics/sparcs/.
Cohort Definition
In order to establish the cohort of patients, we used International Classification of Disease-
9-Clinical Modification (ICD-9-CM) codes to identify patients in the registry who underwent
surgical clipping (ICD-9-CM procedure code 39.51) or endovascular coiling [patient with one
of the following ICD-9-CM procedure codes: 39.52 (should also have a code 88.41 and no
39.51 during the same hospitalization), 39.72, 39.75, 39.76; all these codes correspond to endo-
vascular treatments of cerebral aneurysms and have been used before in the literature][2] for
ruptured (ICD-9-CM diagnosis code 430) cerebral aneurysms between 2009 and 2013. To
avoid bias arising from including patients in the cohort at multiple time points, we only consid-
ered the first intervention each patient received and measured the outcomes associated with
that hospitalization. If patients underwent a different intervention at a later date for a separate
aneurysm we did not reconsider them for the analysis, since they were already censored.
Outcome variables
The primary outcome variable was mortality during the initial hospitalization after treatment
of a ruptured cerebral aneurysm. Secondary outcomes were length-of-stay (LOS) during the
initial hospitalization, the rate of discharge to rehabilitation facility (any facility other than the
patient’s home), and 30-day post-discharge readmission to any hospital.
Exposure variables
The primary exposure variable was the treatment method (surgical clipping versus endovascu-
lar coiling).
Covariates (S1 Table) used for risk-adjustment were age, gender, race (African-American,
Hispanic, Asian, Caucasian, other), and insurance (private, Medicare, Medicaid, uninsured,
other). The comorbidities used for risk adjustment were diabetes mellitus (DM), smoking,
chronic lung disease, hypertension, hypercholesterolemia, peripheral vascular disease (PVD),
congestive heart failure (CHF), coronary artery disease (CAD), history of ischemic stroke, tran-
sient ischemic attack (TIA), alcohol abuse, obesity, chronic renal failure (CRF), and coagulopa-
thy. Only variables that were defined as “present on admission” were considered part of the
patient’s preadmission comorbidity profile.
Statistical analysis
The association of treatment technique with our outcome measures was examined in a multi-
variable setting. Patients undergoing surgical clipping, or endovascular coiling in our cohort
were selected for either procedure based on provider and patient preferences in a non-random
way, before our study was executed. In order to account for this unmeasured confounding, and
to simulate the effect of randomization, we used an instrumental variable analysis, an econo-
metric technique.[9] This analysis controls for unmeasured confounders (such as SAH grade,
or aneurysm location) by creating randomization on the treatment method. It is expected that
this approach will balance the comparison groups in terms of variables we cannot measure.
Such comparisons with instrumental variable analysis have been published before for different
anesthesia techniques,[10] partial versus radical nephrectomy,[11] and stroke center versus no
stroke center care.[12] In all these cases, but particularly in the last example (which used the
same database as our study) the authors did not have data on the baseline NIH stroke scale or
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neurologic status of the patients. This was the reason they used an instrumental variable
analysis.
The regional ratio of coiling (county level coiling ratio—defined as the number of coiled
patients divided by the total number of interventions for cerebral aneurysms in a county) was
used as an instrument. The regional ratio of a procedure has been used before to create pseu-
dorandomization on the treatment method, using an instrumental variable analysis.[13] A
good instrument is not associated with the outcome other than through the exposure variable
of interest (a requirement known as the exclusion restriction criterion).[13] In our case it is
unlikely that the regional ratios of coiling would be associated with treatment mortality in any
way other than the choice of treatment. This has been accepted for similar instruments
(regional ratio of a treatment) in prior literature.[10–12] A two stage least squares (2SLS)
method was used for the calculation of the coefficients. The value of the F statistic in the first
stage of the 2SLS approach was 30, which is consistent with a strong instrument (F
statistic>10), based on a practical rule, published before in the literature.[9]
A probit regression was used for the categorical outcomes (mortality, discharge to rehabili-
tation, 30-day readmission),[14] and a linear regression for the linear outcomes (LOS). The
covariates used for risk adjustment in these models were: age, gender, race, insurance, hospital
ID, and all the comorbidities mentioned previously. Since the coefficients produced by the
probit function are not interpretable, we used the marginal effects of our independent variables
instead. The marginal effects are the partial derivatives of the coefficients, and reflect the
change in the probability of the dependent variable, for 1 unit change in the independent vari-
able, at the average value of all other covariates.
In order to demonstrate the robustness of our data in a sensitivity analysis, we used standard
techniques to account for measured confounding while accounting for clustering at the hospi-
tal level. For categorical outcomes we used a logistic regression model with hospital name as a
random effects variable, while controlling for all the covariates mentioned previously. In an
alternative way to control for confounding, we used a propensity adjusted (with deciles of pro-
pensity score) logistic regression model. We calculated the propensity score of coiling, using a
separate logistic regression model, adjusting for all the covariates mentioned previously. For
continuous outcomes, similar analyses were conducted using linear models. Logarithmic trans-
formation of the values of LOS yielded identical results and is therefore not reported further.
Regression diagnostics were used for all models. The number needed to treat (NNT) was
calculated when appropriate. All results are based on two sided tests, and the level of statistical
significance was set at 0.05. This study, based on 4,098 patients, has sufficient power (90%) at a
5% type I error rate to detect differences in mortality, as small as 10.4%. Statistical analyses
were performed using Stata version 13 (StataCorp, College Station, TX), the 64-bit version of
R.3.1.0 (R Foundation for Statistical Computing), and SPSS version 22 (IBM, Armonk, NY).
Results
Patient characteristics
In the selected study period there were 4,098 patients undergoing treatment for ruptured cere-
bral aneurysms (mean age was 53.8 years, with 59.6% females) who were registered in SPARCS,
2,585 (63.1%) underwent endovascular coiling, and 1,513 (36.9%) underwent surgical clipping.
The characteristic of the two cohorts at baseline can be seen in Table 1.
Inpatient mortality
Overall, 117 (7.7%) inpatient deaths were recorded after clipping and 264 (10.2%) after coiling
(Table 2). Clipping was associated with decreased mortality in comparison to coiling (OR,
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Table 1. Patient characteristics.
All Patients Coiled Clipped
N = 4098 N = 2585 N = 1513
Mean SD Mean SD Mean SD P-Value
Age 53.81 14.25 54.25 14.73 53.05 13.37 <0.0001
N % N % N % P-Value
Gender F 2765 59.6% 1714 66.3% 1051 69.5% 0.038
M 1333 28.7% 871 33.7% 462 30.5%
Diabetes Mellitus - 3686 79.4% 2318 89.7% 1368 90.4% 0.452
+ 412 8.9% 267 10.3% 145 9.6%
Smoking - 3039 65.5% 1903 73.6% 1136 75.1% 0.318
+ 1059 22.8% 682 26.4% 377 24.9%
Obesity - 3846 82.8% 2418 93.5% 1428 94.4% 0.312
+ 252 5.4% 167 6.5% 85 5.6%
Transient Ischemic Attack - 3931 84.7% 2493 96.4% 1438 95.0% 0.033
+ 167 3.6% 92 3.6% 75 5.0%
Ischemic Stroke - 4016 86.5% 2532 97.9% 1484 98.1% 0.818
+ 82 1.8% 53 2.1% 29 1.9%
Coronary Artery Disease - 3709 79.9% 2328 90.1% 1381 91.3% 0.205
+ 389 8.4% 257 9.9% 132 8.7%
Chronic Obstructive Pulmonary Disease - 3642 78.4% 2307 89.2% 1335 88.2% 0.328
+ 456 9.8% 278 10.8% 178 11.8%
Congestive Heart Failure - 3862 83.2% 2421 93.7% 1441 95.2% 0.037
+ 236 5.1% 164 6.3% 72 4.8%
Coagulopathy - 3998 86.1% 2518 97.4% 1480 97.8% 0.463
+ 100 2.2% 67 2.6% 33 2.2%
Chronic Renal Failure - 4083 87.9% 2576 99.7% 1507 99.6% 0.794
+ 15 0.3% 9 0.3% 6 0.4%
Hypertension - 1827 39.3% 1194 46.2% 633 41.8% 0.007
+ 2271 48.9% 1391 53.8% 880 58.2%
Hypercholesterolemia - 3362 72.4% 2108 81.5% 1254 82.9% 0.292
+ 736 15.9% 477 18.5% 259 17.1%
Alcohol - 3890 83.8% 2468 95.5% 1422 94.0% 0.039
+ 208 4.5% 117 4.5% 91 6.0%
Peripheral Vascular Disease - 3962 85.3% 2484 96.1% 1478 97.7% 0.007
+ 136 2.9% 101 3.9% 35 2.3%
doi:10.1371/journal.pone.0137946.t001
Table 2. Outcomes.
Total Coiled Clipped P-value
Death, % 381 (9.29%) 264 (10.21%) 117 (7.73%) 0.008
Discharge to rehabilitation, % 2272 (55.44%) 1324 (51.22%) 948 (62.66%) <0.0001
30-day readmission, % 287 (7.00%) 179 (6.92%) 108 (7.14%) 0.796
Length of stay, SD 17 (14) 16 (13) 18 (13) <0.0001
SD: standard deviation.
doi:10.1371/journal.pone.0137946.t002
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0.73; 95% CI, 0.58 to 0.91) in unadjusted analysis. Likewise, there was no association of treat-
ment technique with mortality (ME, -0.56; 95% CI, -1.03 to 0.02) after using a probit regression
with instrumental variable analysis (Table 3). This persisted in a mixed effects logistic regres-
sion model (OR, 0.88; 95% CI, 0.69 to 1.14) and a propensity score adjusted model (OR, 0.83;
95% CI, 0.65 to 1.04).
Discharge to rehabilitation
Overall, 948 (62.7%) were discharged to rehabilitation after clipping and 1,324 (51.2%) after
coiling (Table 2). Clipping was associated with an increased rate of discharge to rehabilitation
in comparison to coiling (OR, 1.54; 95% CI, 1.34 to 1.78) in the unadjusted analysis. This per-
sisted (ME, 0.63; 95% CI, 0.24 to 1.01) after using a probit regression with instrumental variable
analysis (Table 3). We found similar results in a mixed effects logistic regression model (OR,
1.65; 95% CI, 1.39 to 1.95) and a propensity score adjusted model (OR, 1.69; 95% CI, 1.45 to
1.96). This corresponded to 9 patients needed to be treated with coiling to prevent one dis-
charge to rehabilitation.
30-day readmission
Overall, 108 (7.1%) were readmitted within 30-days after clipping and 179 (6.9%) after coiling
(Table 2). Clipping was not associated with increased rate of 30-day readmission in comparison
to coiling (OR, 1.03; 95% CI, 0.80 to 1.32) in the unadjusted analysis. Similarly, there was no
association (ME, -0.30; 95% CI, -0.82 to 0.22) after using a probit regression with instrumental
variable analysis (Table 3). We found similar results in a mixed effects logistic regression
model (OR, 1.05; 95% CI, 0.81 to 1.38) and a propensity score adjusted model (OR, 1.05; 95%
CI, 0.82 to 1.35).
Length-of-stay
The average LOS was 18 days (SD 13) after clipping, and 16 days (SD 13) after coiling
(Table 2). Clipping was not associated with increased LOS in comparison to coiling (beta, 1.00;
95% CI, -1.14 to 1.16) in the unadjusted analysis. This persisted (ME, 1.72; 95% CI, -3.39 to
6.84) after using a linear regression with instrumental variable analysis (Table 3). We found
similar results in a mixed effects linear regression model (beta, 1.26; 95% CI, -0.10 to 2.42) and
a propensity score adjusted linear regression model (beta, 1.16; 95% CI, -0.02 to 2.33).
Discussion
Using a comprehensive all-payer cohort of aneurysmal SAH patients in New York State we did
not identify an association of treatment method with mortality, LOS, or 30-day readmission.
Clipping was associated with higher rate of discharge to rehabilitation. Our results were robust
when considering several advanced observational techniques to account for measured and
unmeasured confounders. Endovascular coiling has seen explosive growth in recent years,
especially after the publication of randomized trials supporting that it offers a survival benefit,
in comparison to clipping, for patients with SAH.[7] However, the relative effectiveness of
these two treatment interventions for ruptured cerebral aneurysms in the community, has not
been established yet.[2, 3]
Several randomized trials have demonstrated short and long-term benefits of coiling in
comparison to clipping for patients with ruptured cerebral aneurysms. Molyneux et al,[4] in
their landmark ISAT study, demonstrated that 30.6% of patients undergoing clipping were
dead or dependent one year after intervention, in comparison to 23.7% after coiling. Long-
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term follow up results of this trial demonstrated persistence of this survival benefit 5 years post-
operatively, despite the increased risk of rebleeding for coiled aneurysms.[15] However, survi-
vors undergoing either treatment had similar neurologic outcomes. Initial criticism for the
ISAT trial focused on the selection of anterior circulation aneurysms and the inclusions of
mainly European centers.[5] A single center trial in the United States, designed to address
these potential short-comings, confirmed the superiority of coiling in 1-year postoperative sur-
vival.[6] The non-invasive nature of endovascular techniques, and these encouraging results
have led to their explosive growth. However, results of well-designed, controlled trials do not
always translate to real-world effectiveness.[16, 17] Rigorous studies of the latter for SAH
patients are lacking.
Traditional techniques used in most observational studies to control for measured con-
founding are not ideal for such a study. The selection of patients for either treatment prior to
the analysis introduces significant unmeasured confounding. Patients may be selected for coil-
ing because of favorable anatomy, aneurysm location, or general health. Physician or patient
preference, as well as provider training and specialty might affect that decision too. Not
accounting for this dimension of confounding puts the robustness of the findings of an obser-
vational study into question. Our study, purposefully addressing this potential bias, utilized an
econometric technique, to account for unmeasured confounding and simulate pseudo-ran-
domization. We used regional coiling ratio, a well-established type of instrument,[13] for our
analytic strategy.
The present analysis did not demonstrate a difference in inpatient mortality between the
patients undergoing surgical clipping and endovascular coiling. This is not in accordance with
the survival benefit of clipping demonstrated by all prior randomized trials.[4, 6, 15] It is likely
that the widespread availability of coiling, and the use of this technique by potentially less expe-
rienced practitioners blunted the effect seen in randomized trials. In addition, we identified an
association of clipping with a higher rate of discharge to rehabilitation. Although disposition
does not necessarily reflect functional outcome, some investigators have used it as such.[2, 3]
The definitive comparison of the two techniques on functional outcomes, however, can only be
done in prospective registries. In this direction, the NeuroPoint Alliance has created the first
module for a cerebrovascular registry, with results expected in the near future.[18]









ME (95% CI) P-
value
ME (95% CI) P-
value
ME (95% CI) P-
value
ME (95% CI) P-
value
Instrumental variable analysis* -0.56 (-1.03 to
0.02)
0.130 0.63 (0.24 to 1.01) <0.001 -0.30 (-0.82 to
0.22)
0.259 1.72 (-3.39 to
6.84)
0.509
OR (95% CI) P-
value
OR (95% CI) P-
value
OR (95% CI) P-
value






0.200 1.65 (1.39 to 1.95) <0.001 1.05 (0.81 to
1.38)







0.110 1.69 (1.45 to 1.96) <0.001 1.05 (0.82 to
1.35)
0.707 1.16 (-0.02 to
2.33)
0.070
ME: marginal effects; CI: confidence intervals; OR: odds ratio.
*County coiling ratio was used as an instrument of coiling.
⌘Hospital ID was used as a random effects variable.
¶The propensity score was calculated using the following variables: sex, race, insurance, medical comorbidities.
§All regressions were based on linear models.
doi:10.1371/journal.pone.0137946.t003
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Our study has several limitations common to administrative databases. Residual confound-
ing could account for some of the observed associations. However, this is minimized to the
extent that we are using a good instrument for coiling. The F statistic in our analysis suggests a
strong instrument. In addition, coding inaccuracies will undoubtedly occur and can affect our
estimates. However, several reports have demonstrated that coding for aneurysm and cerebro-
vascular disease has shown nearly perfect association with medical record review [19, 20].
Although SPARCS includes all hospitals from the entire New York State, the generalization of
this analysis to the entire US population is uncertain. SPARCS does not provide any clinical
information on the structure, size, or location of the aneurysms, which are important factors in
cerebrovascular neurosurgery. However, the use of the instrumental variable analysis is
attempting to control for unknown confounders such as these.
Additionally, we were lacking post-hospitalization, and long-term data on our patients.
Quality metrics (i.e. modified Rankin score) are also not available through this database, and
therefore we cannot compare the two treatment techniques on these outcomes. Although dis-
charge to home does not always indicate a good outcome, discharge status has been shown [21]
to correlate well with modified Rankin Scale score and provides important insight into differ-
ences within and between treatment modalities. Finally, causality cannot be definitively estab-
lished based on observational data, despite the use of advanced techniques, such as the
instrumental variable analysis.
Conclusions
Despite the widespread use of coiling in the treatment of ruptured cerebral aneurysms, there is
still considerable debate about the relative effectiveness of surgical clipping and endovascular
coiling in real world practice. Using a comprehensive all-payer cohort of patients in New York
State with aneurysmal SAH we did not identify an association of treatment method with mor-
tality, LOS, or 30-day readmission. Clipping was associated with higher rate of discharge to
rehabilitation. Our results were robust when considering several advanced observational tech-
niques to account for measured and unmeasured confounders.
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